The vital role of inclusive publishing in advancing science
Explore how inclusive publishing offers scientific and societal value beyond traditional citation metrics.
Explore how inclusive publishing offers scientific and societal value beyond traditional citation metrics.
Read more about the BMJ’s response to the US government instruction for CDC authors to withdraw articles reporting sex and gender data.
Research from higher-status institutions and countries is postulated to receive more favourable peer review. A recent article suggests this may not be the case.
Find out how media outlets reported on COVID-19 preprints in the early months of the pandemic.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.
PLOS ONE now offers Registered Reports, shifting peer review focus from results to the quality of study design. Is this part of the future of open science?
The reproducibility crisis is linked to publication bias and a paucity of negative data. Find out how and why to get such data published.
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.